China Hpv Testing And Pap Test Market Size & Outlook
China hpv testing and pap test market, 2018-2030 (US$M)
Related Markets
China hpv testing and pap test market highlights
- The China hpv testing and pap test market generated a revenue of USD 176.5 million in 2023 and is expected to reach USD 469.9 million by 2030.
- The China market is expected to grow at a CAGR of 15% from 2024 to 2030.
- In terms of segment, pap test was the largest revenue generating type in 2023.
- HPV Test is the most lucrative type segment registering the fastest growth during the forecast period.
Hpv testing and pap test market data book summary
| Market revenue in 2023 | USD 176.5 million |
| Market revenue in 2030 | USD 469.9 million |
| Growth rate | 15% (CAGR from 2023 to 2030) |
| Largest segment | Pap test |
| Fastest growing segment | HPV Test |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pap Test, HPV Test |
| Key market players worldwide | Abbott Laboratories, Qiagen NV, Becton Dickinson & Co, Quest Diagnostics Inc, Hologic Inc, Roche Holding AG ADR, Femasys Inc, Thermo Fisher Scientific Inc, BioMerieux SA, Seegene, Arbor Vita Corporation, Nurx |
Other key industry trends
- In terms of revenue, China accounted for 4.1% of the global hpv testing and pap test market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China hpv testing and pap test market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 469.9 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
HPV Testing And Pap Test Market Scope
HPV Testing And Pap Test Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
China hpv testing and pap test market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hpv testing and pap test market will help companies and investors design strategic landscapes.
Pap test was the largest segment with a revenue share of 63.29% in 2023. Horizon Databook has segmented the China hpv testing and pap test market based on pap test, hpv test covering the revenue growth of each sub-segment from 2018 to 2030.
- China HPV Testing And Pap Test Type Outlook (Revenue, USD Million, 2018-2030)
- Pap Test
- HPV Test
- China HPV Testing And Pap Test Application Outlook (Revenue, USD Million, 2018-2030)
- Cervical Cancer Screening
- Vaginal Cancer Screening
- China HPV Testing And Pap Test Product Outlook (Revenue, USD Million, 2018-2030)
- Instruments
- Consumables
- Services
- China HPV Testing And Pap Test Technology Outlook (Revenue, USD Million, 2018-2030)
- PCR
- Immunodiagnostics
- Other Technologies
- China HPV Testing And Pap Test End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals & Clinics
- Laboratories
- Others
Reasons to subscribe to China hpv testing and pap test market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of China hpv testing and pap test market databook
-
Our clientele includes a mix of hpv testing and pap test market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the China hpv testing and pap test market , including forecasts for subscribers. This country databook contains high-level insights into China hpv testing and pap test market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
China hpv testing and pap test market size, by type, 2018-2030 (US$M)
China HPV Testing And Pap Test Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
